Delivery Order SPE2DB22D2007-SPE2DB25FH8AR

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,480,890 tablets of Methylphenidate ER 54 mg to the Defense Logistics Agency (DLA). The $1,008.93 firm fixed-price award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 13, 2024 with a completion date of November 14, 2024. The award is not designated under any set-aside program. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award to Amerisourcebergen Drug Corp, issued by the Defense Logistics Agency (DLA), is for the delivery of 4,565,425,065 tablets of Methylphenidate ER 36 mg. The $3,063.36 firm fixed price delivery order has an ultimate completion date of August 13, 2024. Amerisourcebergen is the prime contractor and is not operating under a set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award is for the delivery of 4,564,084,308 tablets of methylphenidate extended-release 36 mg to the Defense Logistics Agency (DLA) Troop Support Medical program, which supports medical treatment facilities for the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, on March 26, 2024 as a firm fixed price delivery order worth $1,602.48. The...
This federal contract award is for the delivery of 4,564,222,164 tablets of Methylphenidate ER 36 mg, with a ceiling value of $3,947.71. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance runs through April 10, 2024. This award does not have any set-aside designation, indicating...
This federal contract award is for the delivery of 4,566,528,747 units of Methylphenidate ER 18 mg tablets, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,827.88 firm fixed-price contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024 by the Defense Logistics Agency (DLA), a defense agency. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of 100 tablets of 36 mg Extended Release Methylphenidate, a prescription medication, to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp's Corporate Office Division, has a firm fixed price of $2,992.12 and a completion date of July 3, 2024. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Methylphenidate ER 36 mg tablets. The $1,503.22 firm fixed-price delivery order was awarded on November 14, 2024, with a completion date of November 15, 2024. The contract has no set-aside designation, indicating open competition. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award is for the delivery of 4,562,586,801 units of Methylphenidate ER 36 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,245.04 and a period of performance through October 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,481.23 firm-fixed-price delivery order is for the supply of 4,566,619,577 tablets of Methylphenidate ER 18 mg. The contract has an ultimate completion date of November 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,710.36 firm fixed-price delivery order is for the supply of 4,566,250 units of methylphenidate ER 36 mg tablets, a medication commonly used to treat attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. This...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8AR
    Delivery Order

This federal contract award is for the delivery of 4,566,810,759 tablets of Methylphenidate ER 36 mg, a prescription medication, to the Defense Logistics Agency (DLA). The $1,646.73 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024, with a completion date of December 31, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 3/31/25, 9:32 AM